These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1369203)

  • 21. The prevalence of patent interferences in gene technology.
    Merz JF; Henry MR
    Nat Biotechnol; 2004 Feb; 22(2):153-4. PubMed ID: 14755283
    [No Abstract]   [Full Text] [Related]  

  • 22. Premier funds biotechnology.
    Scott L
    Mod Healthc; 1996 Apr; 26(18):50. PubMed ID: 10157168
    [No Abstract]   [Full Text] [Related]  

  • 23. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 24. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 25. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 26. Good faith gone bad.
    Bialy H
    Nat Biotechnol; 2000 Nov; 18(11):1123. PubMed ID: 11062389
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 28. Startups hope federal study fixes SBIR flaws.
    Basu P
    Nat Biotechnol; 2004 Jun; 22(6):644. PubMed ID: 15175671
    [No Abstract]   [Full Text] [Related]  

  • 29. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 30. Dutch bill unlikely to revive industry.
    Heselmans M
    Nat Biotechnol; 2000 Dec; 18(12):1240. PubMed ID: 11101796
    [No Abstract]   [Full Text] [Related]  

  • 31. The prodigal son: the relationship between patent law and health care.
    Bostyn SJ
    Med Law Rev; 2003; 11(1):67-120. PubMed ID: 14606473
    [No Abstract]   [Full Text] [Related]  

  • 32. Bid to limit prices on drugs using 'public' discoveries.
    Wadman M
    Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotechnology in pharmaceuticals: the Japanese challenge.
    Dibner MD
    Science; 1985 Sep; 229(4719):1230-5. PubMed ID: 3898361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles, property rights, and profits: historical reflections on university/industry relations.
    Kevles DJ
    Account Res; 2001; 8(4):293-307. PubMed ID: 12481797
    [No Abstract]   [Full Text] [Related]  

  • 35. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 36. Are small biotechs still underselling themselves?
    Ransom J
    Nat Biotechnol; 2006 May; 24(5):477. PubMed ID: 16680112
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotechnology in India.
    Ghosh PK
    Australas Biotechnol; 1993; 3(4):214-5, 218-22. PubMed ID: 7764132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roger Beachy. Interview by Emily Waltz.
    Beachy R
    Nat Biotechnol; 2010 Jan; 28(1):11-2. PubMed ID: 20062028
    [No Abstract]   [Full Text] [Related]  

  • 39. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

  • 40. Taking university research into the marketplace.
    Omenn GS
    N Engl J Med; 1982 Sep; 307(11):694-700. PubMed ID: 6955593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.